Sandoz

Sandoz, the generic pharmaceuticals division of Novartis, is a global leader in developing, producing and marketing medicines no longer protected by patents, along with pharmaceutical and biotechnological active substances. This broad portfolio of high-quality and cost-effective products makes affordable medicines available to patients worldwide and helps stabilize healthcare systems.

Sandoz also is committed to the key growth area of creating follow-on versions of biotechnology medicines.

Novartis is the only major pharmaceutical company to achieve leadership positions in both patented prescription drugs and generic pharmaceuticals. Sandoz plays an increasingly important role in our strategy of offering a range of medicines to patients, physicians and healthcare providers worldwide.

Visit the Sandoz website